NFKB1 and cardiac hypertrophy: The NF-κB signaling pathway is mainly considered as the central mediator of the inflammatory process, but it has also been shown to be implicated in the development of pathological cardiac hypertrophy (Freund et al., 2005; Zelarayan et al., 2009; Nakamura and Sadoshima, 2018).